Istituto di Biostrutture e Bioimmagini, C.N.R. and CIRPEB, Via Mezzocannone 16, 80134, Napoli, Italy.
Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Università degli Studi della Campania Luigi Vanvitelli, via Vivaldi 46, 81100, Caserta, Italy.
Sci Rep. 2017 Apr 25;7(1):1138. doi: 10.1038/s41598-017-01337-8.
The Cyclophilin A (CypA)/Apoptosis Inducing Factor (AIF) complex is implicated in the DNA degradation in response to various cellular stress conditions, such as oxidative stress, cerebral hypoxia-ischemia and traumatic brain injury. The pro-apoptotic form of AIF (AIF(Δ1-121)) mainly interacts with CypA through the amino acid region 370-394. The AIF(370-394) synthetic peptide inhibits complex formation in vitro by binding to CypA and exerts neuroprotection in a model of glutamate-mediated oxidative stress. Here, the binding site of AIF(Δ1-121) and AIF(370-394) on CypA has been mapped by NMR spectroscopy and biochemical studies, and a molecular model of the complex has been proposed. We show that AIF(370-394) interacts with CypA on the same surface recognized by AIF(Δ1-121) protein and that the region is very close to the CypA catalytic pocket. Such region partially overlaps with the binding site of cyclosporin A (CsA), the strongest catalytic inhibitor of CypA. Our data point toward distinct CypA structural determinants governing the inhibitor selectivity and the differential biological effects of AIF and CsA, and provide new structural insights for designing CypA/AIF selective inhibitors with therapeutic relevance in neurodegenerative diseases.
亲环素 A(CypA)/凋亡诱导因子(AIF)复合物与各种细胞应激条件下的 DNA 降解有关,如氧化应激、脑缺氧缺血和创伤性脑损伤。促凋亡形式的 AIF(AIF(Δ1-121))主要通过氨基酸区域 370-394 与 CypA 相互作用。AIF(370-394)合成肽通过与 CypA 结合在体外抑制复合物形成,并在谷氨酸介导的氧化应激模型中发挥神经保护作用。在这里,通过 NMR 光谱和生化研究映射了 AIF(Δ1-121)和 AIF(370-394)在 CypA 上的结合位点,并提出了复合物的分子模型。我们表明,AIF(370-394)与 CypA 相互作用的表面与 AIF(Δ1-121)蛋白识别的表面相同,并且该区域非常接近 CypA 催化口袋。该区域与环孢菌素 A(CsA)的结合位点部分重叠,环孢菌素 A 是 CypA 的最强催化抑制剂。我们的数据表明,CypA 的结构决定因素决定了抑制剂的选择性和 AIF 和 CsA 的不同生物学效应,并为设计具有神经退行性疾病治疗相关性的 CypA/AIF 选择性抑制剂提供了新的结构见解。